Latest & greatest articles for atrial fibrillation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on atrial fibrillation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on atrial fibrillation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for atrial fibrillation

701. Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis

Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis Andersen L V, Vestergaard P, Deichgraeber P, Lindholt J S, Mortensen L S, Frost L CRD summary This review concluded that warfarin reduced the risk (...) of stroke and systemic embolism in patients with non-valvular atrial fibrillation, but increased the risk of major bleeding. There were several limitations with the included trials and the reporting in the review, such as no validity assessment and potential bias, so the authors' conclusions should be interpreted with caution. Authors' objectives To assess the efficacy of warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation. Searching MEDLINE, EMBASE

DARE.2008

702. Does minimal-access aortic valve replacement reduce the incidence of postoperative atrial fibrillation?

Does minimal-access aortic valve replacement reduce the incidence of postoperative atrial fibrillation? Does minimal-access aortic valve replacement reduce the incidence of postoperative atrial fibrillation? Does minimal-access aortic valve replacement reduce the incidence of postoperative atrial fibrillation? Murtuza B, Pepper J R, Stanbridge R D, Darzi A, Athanasiou T CRD summary The authors discovered there may be no difference in rates of postoperative atrial fibrillation after minimal (...) access aortic valve replacement compared to conventional aortic valve replacement and recommended further research. Although the conclusions appeared to be supported by the evidence, the limited literature search and lack of information about study quality mean that some caution in interpretation may be required. Authors' objectives To compare the incidence of postoperative atrial fibrillation associated with minimal access aortic valve replacement and conventional aortic valve replacement. Searching

DARE.2008

703. Radiofrequency catheter ablation of the pulmonary veins for treatment of atrial fibrillation

Radiofrequency catheter ablation of the pulmonary veins for treatment of atrial fibrillation Radiofrequency catheter ablation of the pulmonary veins for treatment of atrial fibrillation Radiofrequency catheter ablation of the pulmonary veins for treatment of atrial fibrillation BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation (...) BlueCross BlueShield Association. Radiofrequency catheter ablation of the pulmonary veins for treatment of atrial fibrillation. Chicago IL: BlueCross BlueShield Association (BCBS). TEC Assessment 23(11). 2008 Authors' objectives The objective of this Assessment is to determine whether radiofrequency catheter ablation improves health outcomes when used as a treatment for patients with atrial fibrillation. Three indications for radiofrequency catheter ablation are addressed: 1) patients with recent onset

Health Technology Assessment (HTA) Database.2008

704. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation Shepherd J (...) , Jones J, Frampton GK, Tanajewski L, Turner D, Price A Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation. Southampton

Health Technology Assessment (HTA) Database.2008

706. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review

Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review Wan Y, Heneghan C, Perera R, Roberts N, Hollowell J, Glasziou P, Bankhead C, Xu Y CRD summary This review concluded that in atrial fibrillation patients (...) patients with atrial fibrillation receiving oral anticoagulation (vitamin-K antagonists). Searching MEDLINE, EMBASE and the Cochrane Library were searched from January 1990 to January 2008 for articles published in any language. Search terms were reported. Reference lists of retrieved trials and review articles were scanned. Study selection Randomised controlled trials (RCTs), prospective cohorts and retrospective studies of vitamin K antagonists in unselected adults with atrial fibrillation were

DARE.2008

707. Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation

Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus (...) on atrial fibrillation Rubboli A, Halperin JL, Juhani Airaksinen KE, Buerke M, Eeckhout E, Freedman SB, Gershlick AH, Schlitt A, Tse HF, Verheugt FW, Lip GY CRD summary The authors concluded that the optimal antithrombotic regime for atrial fibrillation in patients undergoing percutaneous coronary interventions with stenting was undefined. They recommended triple therapy (warfarin, aspirin, clopidogrel) as the most effective regime, but with an increased risk of bleeding. This recommendation may be unreliable

DARE.2008

708. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies

Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies Upadhyay GA, Choudhry NK, Auricchio A, Ruskin J, Singh JP CRD summary This review concluded there were benefits to treating heart failure with cardiac resynchronisation (...) ; patients with atrial fibrillation had greater improvement in ejection fraction, but smaller improvements in functional outcomes than those in sinus rhythm. Mortality was similar in both groups. Given some problems with the review and less reliable data from observational studies, these conclusions should be treated with caution. Authors' objectives To determine the effects of cardiac resynchronisation therapy in patients with atrial fibrillation compared with those in sinus rhythm. Searching MEDLINE

DARE.2008

709. Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies

Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies Liu T, Li L, Korantzopoulos P, Liu E, Li G CRD summary (...) The authors concluded that statins may be effective in preventing atrial fibrillation especially in postoperative patients, but there was insufficient evidence to recommend statins solely to prevent atrial fibrillation. Further research was required. This was generally a well-conducted review and the authors' cautious conclusions reflected the paucity of good-quality evidence. Authors' objectives To examine the association between statins and the development of atrial fibrillation. Searching MEDLINE

DARE.2008

710. Treatment of new-onset atrial fibrillation in noncardiac intensive care unit patients: a systematic review of randomized controlled trials

Treatment of new-onset atrial fibrillation in noncardiac intensive care unit patients: a systematic review of randomized controlled trials Treatment of new-onset atrial fibrillation in noncardiac intensive care unit patients: a systematic review of randomized controlled trials Treatment of new-onset atrial fibrillation in noncardiac intensive care unit patients: a systematic review of randomized controlled trials Kanji S, Stewart R, Fergusson D A, McIntyre L, Turgeon A F, Hebert P C CRD summary (...) The authors found insufficient evidence to make recommendations about standard treatment of noncardiac critically ill patients with new-onset atrial fibrillation. Despite some concerns about the risk of language and publication bias, this was generally a well-conducted review and the authors’ conclusions were likely to be reliable. Authors' objectives To evaluate the efficacy of pharmacological rhythm control treatments for new-onset atrial fibrillation in noncardiac critically ill adult patients

DARE.2008

711. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation Shepherd J (...) , Jones J, Frampton G K, Tanajewski L, Turner D, Price A CRD summary RCTs directly comparing intravenous magnesium sulphate with sotalol were not identified, but the authors did conclude that intravenous magnesium is effective in preventing atrial fibrillation in patients undergoing coronary artery bypass graft when compared to controls. This was a well conducted piece of research, which considered limitations with the included studies. The authors' conclusions are likely to be reliable. Authors

DARE.2008

712. Curative ablation for atrial fibrillation: a systematic review

Curative ablation for atrial fibrillation: a systematic review Curative ablation for atrial fibrillation: a systematic review Curative ablation for atrial fibrillation: a systematic review Gjesdal K, Vist G E, Bugge E, Rossvoll O, Johansen M, Norderhaug I, Ohm O J CRD summary This systematic review concluded that catheter ablation was more effective than drug therapy for atrial fibrillation, but that data on adverse effects was sparse. The review appeared to have been reasonably well conducted (...) , although poor reporting limited the assessment of some sources of bias. The authors' conclusions reflected the evidence presented, but the low quality of the included studies limited the reliability of the conclusions. Authors' objectives To assess the effectiveness of catheter ablation for atrial fibrillation. Searching MEDLINE, MEDLINE In-Process and Other Non-Indexed Citations, EMBASE, The Cochrane Library, meta Register of Controlled Trials and relevant websites were searched to May 2007. Study

DARE.2008

713. Patients with lone atrial fibrillation had low risk of progression to permanent atrial fibrillation, death, congestive heart failure, and stroke

Patients with lone atrial fibrillation had low risk of progression to permanent atrial fibrillation, death, congestive heart failure, and stroke Patients with lone atrial fibrillation had low risk of progression to permanent atrial fibrillation, death, congestive heart failure, and stroke | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Patients with lone atrial fibrillation had low risk of progression to permanent atrial fibrillation, death, congestive heart failure, and stroke Article Text Prognosis Patients with lone atrial fibrillation had low

Evidence-Based Medicine (Requires free registration)2008

714. Accuracy of ECG interpretation in primary care was limited for detecting atrial fibrillation

Accuracy of ECG interpretation in primary care was limited for detecting atrial fibrillation Accuracy of ECG interpretation in primary care was limited for detecting atrial fibrillation | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search (...) for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Accuracy of ECG interpretation in primary care was limited for detecting atrial fibrillation Article Text This article has a correction. Please see: Diagnosis Accuracy of ECG interpretation in primary care was limited for detecting atrial fibrillation Statistics from Altmetric.com No Altmetric data available

Evidence-Based Medicine (Requires free registration)2008

715. Systematic or opportunistic screening was more effective than usual care for detecting new cases of atrial fibrillation

Systematic or opportunistic screening was more effective than usual care for detecting new cases of atrial fibrillation Systematic or opportunistic screening was more effective than usual care for detecting new cases of atrial fibrillation | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Systematic or opportunistic screening was more effective than usual care for detecting new cases of atrial fibrillation Article Text Therapeutics Systematic or opportunistic screening was more effective than usual care for detecting new cases of atrial fibrillation Statistics

Evidence-Based Medicine (Requires free registration)2008

716. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W)

Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W) 18323500 2008 04 29 2008 05 29 2016 11 24 1524-4628 39 5 2008 May Stroke Stroke Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation (...) clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). 1482-6 10.1161/STROKEAHA.107.500199 In ACTIVE-W, oral anticoagulation (OAC) was more efficacious than combined clopidogrel plus aspirin (C+A) in preventing vascular events in patients with atrial fibrillation. However, because OAC carries important bleeding complications, risk stratification schemes have been devised to identify patients for whom the absolute benefits of OAC exceed its risks. Participants were risk-stratified

EvidenceUpdates2008

717. Relation of Recurrence of Atrial Fibrillation After Non-ST-Elevation Acute Myocardial Infarction to Left Atrial Abnormality

Relation of Recurrence of Atrial Fibrillation After Non-ST-Elevation Acute Myocardial Infarction to Left Atrial Abnormality 18157961 2007 12 25 2008 02 06 2016 11 24 0002-9149 101 1 2008 Jan 01 The American journal of cardiology Am. J. Cardiol. Relation of recurrence of atrial fibrillation after non-ST-elevation acute myocardial infarction to left atrial abnormality. 30-4 Atrial fibrillation (AF) is common during the course of acute myocardial infarction and is associated with left atrial (LA (...) ) dilatation. However, the role of LA depolarization abnormality on the electrocardiogram (ECG) in the setting of LA dilatation was not studied in this context. Patients admitted with non-ST-segment elevation myocardial infarction (NSTEMI) who developed new-onset AF (International Classification of Diseases, Ninth Revision code 427.31) were prospectively identified. Baseline ECGs and echocardiograms before the admission event were reviewed. Follow-up was directed toward pertinent cardiovascular events

EvidenceUpdates2008

718. Rhythm control versus rate control for atrial fibrillation and heart failure.

Rhythm control versus rate control for atrial fibrillation and heart failure. 18565859 2008 06 20 2008 06 26 2016 08 03 1533-4406 358 25 2008 Jun 19 The New England journal of medicine N. Engl. J. Med. Rhythm control versus rate control for atrial fibrillation and heart failure. 2667-77 10.1056/NEJMoa0708789 It is common practice to restore and maintain sinus rhythm in patients with atrial fibrillation and heart failure. This approach is based in part on data indicating that atrial fibrillation (...) is a predictor of death in patients with heart failure and suggesting that the suppression of atrial fibrillation may favorably affect the outcome. However, the benefits and risks of this approach have not been adequately studied. We conducted a multicenter, randomized trial comparing the maintenance of sinus rhythm (rhythm control) with control of the ventricular rate (rate control) in patients with a left ventricular ejection fraction of 35% or less, symptoms of congestive heart failure, and a history

NEJM2008

719. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. 18294998 2008 02 25 2008 03 10 2015 06 16 1474-547X 371 9609 2008 Jan 26 Lancet (London, England) Lancet Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. 315-21 10.1016/S0140-6736(08)60168-3 Vitamin K (...) antagonists, the current standard treatment for prophylaxis against stroke and systemic embolism in patients with atrial fibrillation, require regular monitoring and dose adjustment; an unmonitored, fixed-dose anticoagulant regimen would be preferable. The aim of this randomised, open-label non-inferiority trial was to compare the efficacy and safety of idraparinux with vitamin K antagonists. Patients with atrial fibrillation at risk for thromboembolism were randomly assigned to receive either

Lancet2008

720. Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial.

Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial. 18854540 2008 10 15 2008 10 20 2016 10 17 1538-3598 300 15 2008 Oct 15 JAMA JAMA Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial. 1784-92 10.1001/jama.300.15.1784 Amiodarone effectively suppresses atrial fibrillation but causes many adverse events. To compare major events in patients randomized (...) to receive episodic amiodarone treatment with those who received continuous amiodarone treatment while still aiming to prevent atrial fibrillation. A randomized trial of 209 ambulatory patients with recurrent symptomatic persistent atrial fibrillation, conducted from December 2002 through March 2007 at 7 Dutch medical centers. Patients were randomly assigned to receive either episodic or continuous amiodarone treatment after electrical cardioversion following amiodarone loading. Episodic amiodarone

JAMA2008